Dementia is one of the diseases that plague the elderly, which is why prevention or reducing the risk of developing the disease is important. However, the symptoms can start developing years before it really sets in, and one of those early indicators is how a person interacts with people.
Express reports that one of the earliest indicators of dementia can be seen in the way a person interacts with other people, whether at home or at work. Social isolation may be an early indicator of the neurodegenerative disease in people. According to the Social Care Institute for Excellence in the United Kingdom, if a person becomes more withdrawn and isolates themselves, or if they are not interested in interacting with other people, it may be the early symptoms of dementia setting in. The organization adds that the person may not even want to talk to other people nor pay attention when they are being talked to.
What makes this symptom a concern is that some people may already be in the early stages of dementia without even knowing it, leaving it untreated. On the other hand, as it is a symptom, the feeling of isolation or the need to be withdrawn may indicate another condition.
Another early symptom of the condition is, as Express also reports, is difficulty planning or organizing or making decisions. According to experts, because the disease occurs as the brain deteriorates with age, the deterioration of the brain is much quicker in those with dementia. They begin to lose focus and will usually need help from friends and family in making day to day decisions. People with dementia will also have trouble controlling their emotions or will see or hear things that other people do not. In a way, if they are telling the truth, they can easily be doubted or they can seem like they are deliberately ignoring issues.
It bears remembering that dementia is mainly an umbrella term for many other neurodegenerative conditions. Alzheimer’s disease, vascular dementia, frontotemporal dementia, and dementia with Lewy bodies are all types of the disease, each with their own causes. It is highly advised to consult a doctor for a proper diagnosis.


FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Sanofi, Regeneron Expand Drug Partnership in $8 Billion Deal
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal
Hengrui Shares Rise on $2.6 Billion Novo Nordisk Obesity Drug Deal
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
HUTCHMED, AstraZeneca Seek FDA Approval for Lung Cancer Combo
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
U.S. Issues Cuba Health Alert as Illnesses Rise 



